Thursday, May 15, 2014 11:08:23 AM
Read more: Amarantus Announces Positive Phase 2a Data for Eltoprazine in Adult ADHD - FierceBiotech http://www.fiercebiotech.com/press-releases/amarantus-announces-positive-phase-2a-data-eltoprazine-adult-adhd#ixzz31nUILos9
Subscribe at FierceBiotech
China Update? Any idea.
post# 100982
http://www.fiercebiotech.com/press-releases/amarantus-announces-positive-phase-2a-data-eltoprazine-adult-adhd
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM